Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome



Rating:

Share or cite this content

Citations should be made in the following way:
H. Bellon (LEUVEN, Belgium). Polymorphisms in immunosuppression transporters affect outcome after lung transplantation.. 1560

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 Differential gene expression of aquaporins (AQP) in lung transplant recipients with acute lung rejection. Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Immunophenotype and gene signature of long-term survivors with normal allograft function after lung transplantation Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 Positive impact of tacrolimus-based immunosuppression after lung transplantation – an analysis of potential risk factors for long-term survival Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Gene expression markers to segregate lung transplant rejection phenotypes Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Donor and recipient NOD2/CARD15 mutations associate with lung function decline following allogeneic stem cell transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 192s Year: 2006 Current outcome after lung transplantation Source: Annual Congress 2012 - Lung transplantation in 2012: where are we? Year: 2012 Pretransplant factors influencing survival in cystic fibrosis (CF) patients after lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006 Up-regulation of γ-glutamyl-cysteine-synthetase gene expression after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001 The use of mTOR inhibitors is associated with improved survival in lung transplant recipients Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020 The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Genetic variation in the STAT3 gene has an impact on survival after lung transplantation Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome Year: 2017 Inflammatory mediators associated with bone metabolism in patients awaiting lung transplantation Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Factors affecting lung function in adult cystic fibrosis patients after lung transplantation. Source: International Congress 2018 – Evolving approaches to differential diagnosis Year: 2018 Multi-omics profiling predicts allograft function after lung transplantation Source: Eur Respir J, 59 (2) 2003292; 10.1183/13993003.03292-2020 Year: 2022 Specificities of the paediatric lung transplant recipient Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005